These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27995540)

  • 1. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
    Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
    World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE.
    Romero R; Chaiworapongsa T; Savasan ZA; Hussein Y; Dong Z; Kusanovic JP; Kim CJ; Hassan SS
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):558-67. PubMed ID: 22578261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
    Abe H; Okada-Tsuchioka M; Kajitani N; Omori W; Itagaki K; Shibasaki C; Boku S; Matsuhisa T; Takebayashi M
    Neuropsychopharmacol Rep; 2023 Sep; 43(3):359-364. PubMed ID: 37337402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.
    Romero R; Espinoza J; Hassan S; Gotsch F; Kusanovic JP; Avila C; Erez O; Edwin S; Schmidt AM
    J Perinat Med; 2008; 36(5):388-98. PubMed ID: 18593373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
    Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
    J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
    Xian N; Chen W; Zhang Y; Li J; Zhang N; Ye Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):493-9. PubMed ID: 26311638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
    Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
    Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
    Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H
    Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of sRAGE, HMGB1, AGE, and S100A8/A9 Concentrations in Plasma and in Serum-Extracted Extracellular Vesicles of Pregnant Women With Preterm Premature Rupture of Membranes.
    Bouvier D; Giguère Y; Blanchon L; Bujold E; Pereira B; Bernard N; Gallot D; Sapin V; Forest JC
    Front Physiol; 2020; 11():609. PubMed ID: 32655405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.
    Buhimschi CS; Baumbusch MA; Dulay AT; Oliver EA; Lee S; Zhao G; Bhandari V; Ehrenkranz RA; Weiner CP; Madri JA; Buhimschi IA
    Am J Pathol; 2009 Sep; 175(3):958-75. PubMed ID: 19679874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.
    Wang J; Wang H; Shi J; Ding Y
    Int J Clin Exp Pathol; 2015; 8(10):12028-40. PubMed ID: 26722388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues.
    Chen W; Zhang Y; Yue C; Ye Y; Chen P; Peng W; Wang Y
    Gynecol Obstet Invest; 2017; 82(4):388-397. PubMed ID: 27505171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of high mobility group box protein 1 on the Kupffer cells of rats with severe burn and the role of receptor for advanced glycation end products in the process].
    Sun L; Chen XL; Guo F; Wang F; Liu S; Liang X; Wang RS; Wang YJ; Sun YX
    Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):158-61. PubMed ID: 23985205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
    Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
    PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
    Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Mobility Group-Box 1 (HMGB1) levels are increased in amniotic fluid of women with intra-amniotic inflammation-determined preterm birth, and the source may be the damaged fetal membranes.
    Baumbusch MA; Buhimschi CS; Oliver EA; Zhao G; Thung S; Rood K; Buhimschi IA
    Cytokine; 2016 May; 81():82-7. PubMed ID: 26954343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
    Clin Biochem; 2011 Jun; 44(8-9):601-4. PubMed ID: 21211520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.
    Zhang BF; Song W; Wang J; Wen PF; Zhang YM
    J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.